Evidence-Based Medicine Guidelines
Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Recombinant Interferon Beta for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______.
Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______. Accessed May 28, 2022.
Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______
Recombinant Interferon Beta for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2022 May 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
ID - 451266
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
